セレイドセラピューティクス - 細胞治療(造血幹細胞)
JP
EN
TOP
About Celaid
About Celaid
Message
Management Philosophy
Corporate Profile
Access
Member
Technology & Innovation
Technology & Innovation
About hematopoietic stem cells
What are hematopoietic stem cells
The growing need for the application of hematopoietic stem cells in cell therapy
Challenges in hematopoietic stem cell transplants
Our technologies
In-vitro expansion technology
Our areas of technological excellence
Our Business
Our Business
Our goals
The development of new cell therapies for the treatment of leukemia and other blood cancers and genetic disorders
Support for regenerative medicine and drug discovery research around the world
Business model
Platform technology development and clinical development
The value chain
News
News
Contact
Contact
Privacy
Policy
JP
Japanese
EN
English
News
Home
News
2024
3
NEWS
R&D
2024.03.28
FBRI and Celaid have executed a collaborative research agreement for vascular regeneration products derived from human hematopoietic stem cells
R&D
2024.03.22
Chosen for the New Energy and Industrial Technology Development Organization (NEDO) Deep Tech Startup Support Project (DTSU)
Copyright© セレイドセラピューティクス - 細胞治療(造血幹細胞) , 2024 All Rights Reserved Powered by
STINGER
.
